ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding ImageneBio, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 42 | 34 | −8 |
| Shares | 26.2M | 26.3M | +17.7K (+0.1%) |
| Value | $93.2M | $69.9M | −$23.3M (−25.0%) |
New holders (2)
Institutions that held ImageneBio, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 10,199 | $27.0K | 0.00% |
| Farther Finance Advisors, LLC | 50 | $133 | 0.00% |
Sold out (10)
Institutions that held ImageneBio, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,343,496 | $4.77M |
| HealthCor Management, L.P. | 220,082 | $781.0K |
| Qube Research & Technologies Ltd | 19,201 | $68.0K |
| Goldman Sachs Group Inc | 12,428 | $44.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,472 | $9.00K |
| BNP Paribas Arbitrage, SA | 976 | $3.46K |
| MUFG Americas Holdings Corp | 450 | $2.00K |
| Royal Bank of Canada | 231 | $1.00K |
| China Universal Asset Management Co., Ltd. | 340 | $1.00K |
| Daiwa Securities Group Inc. | 105 | $0 |